teal triangle graphic

Alkermes Pathways Research Awards®

About Pathways

With millions of people impacted by neurological disorders, more research is urgently needed to advance science in this area. The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience.

The Alkermes Pathways Research Awards program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to schizophrenia or bipolar disorder.

Learn about previous awardees

Supporting Early-Career Researchers 

Watch this video to learn about how Pathways Research Awards funding has impacted the work of previous recipients.  

scientist who received a grant from alkermes

Portrait of Richard Craig Hopkinson VP

Great science is the foundation for everything we do at Alkermes, and our support for these innovative research projects is an extension of that commitment. As the Pathways program continues to evolve, we are proud of its impact to date in supporting the work of early-career researchers.

Craig Hopkinson,
Executive Vice President, Research & Development and Chief Medical Officer 

Areas of Interest

Schizophrenia & Bipolar I Disorder 
  • Preclinical, clinical, translational and epidemiological research
  • Research on treatment and patient- centered outcomes
  • Clinical and health economic outcomes using real-world data
  • Outcomes research supporting continuity of care utilizing telehealth or other technology-based approaches

Selection Criteria

All applications will be formally reviewed by an Independent Review Committee comprising prominent researchers in the relevant field. The Review Committee has final responsibility for selection of Awardees.

When the Review Committee evaluates a proposal, they will consider criteria, including but not limited to overall impact, candidate, mentor, environment and institutional commitment to the applicant and research plan.

Note that applications are not required to include an Alkermes product. 

General Eligibility Criteria

The Alkermes Pathways Research Awards program is for investigators who are in the early stages of their career. Research grants will be awarded to applicants who focus on and have demonstrated a commitment to schizophrenia or bipolar disorder.

To be eligible, an applicant must meet the following criteria:

  • Has an M.D., Ph.D., or equivalent
  • Is affiliated with a medical or research center within the United States at the time of application
  • Is within 5 years of initial academic appointment (e.g., assistant professor) or is a current postdoctoral fellow
  • Has a research mentor with extensive experience in the field of schizophrenia or bipolar disorder
  • Has not received a DP2 award or NIH R01 grant at the time of award, but may be the recipient of a career development (K) award or other mentored research grant
  • Is willing and able to accept funding from a for-profit, biopharmaceutical company
  • Is able to complete the proposed research within 2 years
  • Is a citizen or permanent resident of the United States or holder of a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Additional Information

If you require clarification of any information, please submit an inquiry.

Pathways inquiry form   

The Pathways application period is now closed.

2023 applicants will be notified of Review Committee decisions in Q2 2024.

Please return to this page for updates on future application cycles.